Readers: Training Patients To Advocate For Their Illnesses Is ‘A Virtue Not A Sin’
Kaiser Health News gives readers a chance to respond, react and comment on our stories.
The independent source for health policy research, polling, and news.
2,641-2,660 of 4,036 results
Kaiser Health News gives readers a chance to respond, react and comment on our stories.
The nonprofit Leapfrog Group shows nearly half of California hospitals got a grade of C, D or F in patient safety measures — an increase from two years ago.
The advocacy group behind an expensive media blitz opposing Canadian drug imports has deep ties to the drug industry’s largest trade group.
The powerful chairman of the Senate Judiciary Committee wants the Centers for Medicare and Medicaid Services to explain $125 million in overcharges by insurers.
Even though the GOP health plan is stalled by intraparty negotiations, some big insurance changes are still in the works.
In a region where bears outnumber people, a small medical facility sets a modern example for rural hospitals on life support.
Such efforts have previously failed in the face of opposition from the drug industry, which questions their effectiveness and contends prices reflect research and development costs.
Amplifying the "patient voice," those with the rarest afflictions are trained to become powerful advocates for new drugs and legislation that would help the industry.
There are many ways beyond legislative repeal for the Trump administration and congressional Republicans to unravel the Affordable Care Act.
After the collapse of the Republican replacement plan, there may be a way to find consensus and repair the law.
The changes proposed by the administration for the health law marketplaces in 2018 could increase customers’ out-of-pocket costs and reduce the amount they receive in premium tax credits.
The medical supply industry makes a particularly revelatory case study of the difficulties of untangling global trade.
With high-level connections in the Capitol, Parker "Pete" Petit aims to resolve regulatory issues that have haunted his wound care company.
They want the state’s new tobacco tax to help pay for a raise in Medicaid rates, but so far Gov. Jerry Brown has other plans for that money.
Democratic senators want the Justice Department to reveal what it knows about ProPublica’s recent report that HHS Secretary Tom Price’s stock trades were under investigation by former U.S. Attorney Preet Bharara before the Trump administration fired him.
Some urologists use March Madness as an opportunity to market vasectomy services, offering men the excuse to sit on the sofa for three days to watch college basketball while they recover.
The Department of Justice is joining a whistleblower lawsuit in a fraud case against UnitedHealth in which damages could top $1 billion.
As Congress and the White House try to strike a bargain on an Obamacare repeal plan, the insurance industry likes what it’s seeing.
Republicans and Democrats don’t agree on much these days, but both parties want to keep the health law’s provision to allow adults to stay on their parents’ plan until age 26. But that could be hurting the marketplace’s insurance pools.
The Government Accountability Office said it will investigate potential abuses of the orphan drug program, which offers incentives to drugmakers to develop medicines for rare diseases.
© 2026 KFF